Skip to main content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

An official website of the United States government
Grant Details

Grant Number: 5R21CA191610-02 Interpret this number
Primary Investigator: Mcmullen, Carmit
Organization: Kaiser Foundation Research Institute
Project Title: Optimizing Risk Stratification to Manage Early Stage Bladder Cancer
Fiscal Year: 2016


Abstract

¿ DESCRIPTION (provided by applicant): Quality cancer care requires accurate and precise risk stratification, especially for early stage cancers. A large proportion of incident bladder cancer cases are diagnosed at early stage (


Publications

Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
Authors: Garg T. , McMullen C.K. , Leo M.C. , O'Keeffe-Rosetti M.C. , Weinmann S. , Nielsen M.E. .
Source: Cancer, 2020-11-04 00:00:00.0; , .
EPub date: 2020-11-04 00:00:00.0.
PMID: 33146913
Related Citations

Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults.
Authors: Garg T. , Young A.J. , O'Keeffe-Rosetti M. , McMullen C.K. , Nielsen M.E. , Murphy T.E. , Kirchner H.L. .
Source: Urologic Oncology, 2020-05-11 00:00:00.0; , .
EPub date: 2020-05-11 00:00:00.0.
PMID: 32409197
Related Citations

External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system.
Authors: Leo M.C. , McMullen C.K. , O'Keeffe-Rosetti M. , Weinmann S. , Garg T. , Nielsen M.E. .
Source: Urologic Oncology, 2020 Feb; 38(2), p. 39.e21-39.e27.
EPub date: 2019-11-09 00:00:00.0.
PMID: 31711836
Related Citations

Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer.
Authors: McMullen C.K. , Rosetti M.O. , Weinmann S. , Leo M.C. , Nielsen M.E. .
Source: The Permanente Journal, 2019; 23, .
EPub date: 2019-08-19 00:00:00.0.
PMID: 31496500
Related Citations

Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions.
Authors: Garg T. , Young A.J. , O'Keeffe-Rosetti M. , McMullen C.K. , Nielsen M.E. , Lester Kirchner H. , Murphy T.E. .
Source: Cancer, 2018-10-05 00:00:00.0; , .
EPub date: 2018-10-05 00:00:00.0.
PMID: 30289971
Related Citations



Back to Top